Market Cap 3.34B
Revenue (ttm) 1.42B
Net Income (ttm) 9.66M
EPS (ttm) N/A
PE Ratio 143.67
Forward PE 69.89
Profit Margin 0.68%
Debt to Equity Ratio 0.18
Volume 6,914,900
Avg Vol 4,444,790
Day's Range N/A - N/A
Shares Out 387.83M
Stochastic %K 87%
Beta 1.19
Analysts Strong Sell
Price Target $10.55

Company Profile

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services, psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It also treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating diso...

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 602 767 2100
Address:
4800 North Scottsdale Road, Suite 2500, Scottsdale, United States
KirkKerkorkian
KirkKerkorkian Jun. 16 at 8:58 PM
$LFST oh, if the liabilities on this balance sheet could speak… 😱
0 · Reply
Trader_Ty
Trader_Ty Jun. 12 at 11:48 AM
0 · Reply
MITCH1099
MITCH1099 May. 29 at 8:35 PM
$LFST LifeStance Health is delivering strong, profitable growth in outpatient mental health. Q1 2026 Highlights Revenue $403.5M (+21% YoY) Adj. EBITDA $51.1M (+48%) Net income turned positive at $14.2M 2026 Guidance (Raised) Revenue $1.64–1.68B (~17% growth) Adj. EBITDA $200–220M Outlook Analysts forecast 13–15% annual revenue growth and 50% EPS growth. Margin expansion continues toward mid-teens. Valuation $7.80/share. Consensus Buy with average target $9.86–10.72 (27–37%+ upside). Bottom Line Attractive growth story with accelerating profitability and meaningful analyst upside.
1 · Reply
Ld149
Ld149 May. 22 at 3:56 PM
$LFST This stock was supposed to go up after a great Q1 earnings report. But the 35 million sellout of stock pull this back a lot. ON top of that leaderhsip is selling stock like there is no tomorrow.... WTF are you thinking?
1 · Reply
NVDAMillionaire
NVDAMillionaire May. 20 at 7:37 PM
$LFST Outstanding article that hits the mark on LFST's current state. So if you want to refresh your LFST insights or learn about LFST from scratch, this is a must read. https://everyticker.com/quote/LFST/analysis/lifestance-health-from-cash-burn-to-capital-returns-as-ai-driven-productivity-fuels-margin-inflection-nasdaq-lfst
0 · Reply
KirkKerkorkian
KirkKerkorkian May. 20 at 11:13 AM
$LFST @TA_Kongen
0 · Reply
KirkKerkorkian
KirkKerkorkian May. 20 at 11:13 AM
$LFST how. did. this. grow. this. quickly? not. operationally. possible.
1 · Reply
RunnerSignals
RunnerSignals May. 12 at 8:40 PM
3 setups the crowd hasn't priced in yet $WFRD RSI jumped 10pts in one session. $LFST profits up 1900%, institutions buying not retail. $OUST 92% to target, quiet accumulation for 3 days
1 · Reply
OpenOutcrier
OpenOutcrier May. 8 at 11:52 AM
$LFST (-11.9% pre) LifeStance Health prices 35 million share secondary offering at $8.15 https://ooc.bz/l/101594
0 · Reply
KirkKerkorkian
KirkKerkorkian May. 8 at 10:09 AM
$LFST 20% + 6M share shelf - at earnings. really??? 🤔 🧐 🤨
1 · Reply
Latest News on LFST
LifeStance initiated with a Neutral at Goldman Sachs

2026-06-05T10:10:08.000Z - 14 days ago

LifeStance initiated with a Neutral at Goldman Sachs


LifeStance price target raised to $9 from $8 at JPMorgan

2026-05-14T12:29:47.000Z - 5 weeks ago

LifeStance price target raised to $9 from $8 at JPMorgan


LifeStance price target raised to $12 from $11 at BTIG

2026-05-08T13:18:40.000Z - 6 weeks ago

LifeStance price target raised to $12 from $11 at BTIG


LifeStance price target raised to $11 from $10 at Canaccord

2026-05-08T13:04:57.000Z - 6 weeks ago

LifeStance price target raised to $11 from $10 at Canaccord


LifeStance Health Group Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 6 weeks ago

LifeStance Health Group Earnings Call Transcript: Q1 2026


LifeStance Health Group Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 6 weeks ago

LifeStance Health Group Earnings release: Q1 2026


LifeStance Health Group Slides: Q1 2026

May 7, 2026, 8:30 AM EDT - 6 weeks ago

LifeStance Health Group Slides: Q1 2026


LifeStance Health Group Quarterly report: Q1 2026

May 7, 2026, 8:30 AM EDT - 6 weeks ago

LifeStance Health Group Quarterly report: Q1 2026


LifeStance Reports First Quarter 2026 Results

May 7, 2026, 6:00 AM EDT - 6 weeks ago

LifeStance Reports First Quarter 2026 Results


LifeStance to Present at Upcoming Investor Conferences

Apr 29, 2026, 4:10 PM EDT - 7 weeks ago

LifeStance to Present at Upcoming Investor Conferences


LifeStance Health Group Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

LifeStance Health Group Proxy statement: Proxy filing


LifeStance Health Group Proxy statement: Proxy filing

Apr 22, 2026, 8:00 AM EDT - 2 months ago

LifeStance Health Group Proxy statement: Proxy filing


LifeStance price target raised to $9 from $8 at Barclays

2026-03-06T10:52:09.000Z - 3 months ago

LifeStance price target raised to $9 from $8 at Barclays


LifeStance price target raised to $10 from $9 at Canaccord

2026-02-26T14:15:56.000Z - 4 months ago

LifeStance price target raised to $10 from $9 at Canaccord


LifeStance price target raised to $12 from $10 at UBS

2026-02-26T13:42:01.000Z - 4 months ago

LifeStance price target raised to $12 from $10 at UBS


LifeStance price target raised to $9 from $8 at KeyBanc

2026-02-26T11:52:36.000Z - 4 months ago

LifeStance price target raised to $9 from $8 at KeyBanc


LifeStance price target raised to $10 from $8 at BMO Capital

2026-02-25T19:00:19.000Z - 4 months ago

LifeStance price target raised to $10 from $8 at BMO Capital


LifeStance Health Group Earnings Call Transcript: Q4 2025

Feb 25, 2026, 8:30 AM EST - 4 months ago

LifeStance Health Group Earnings Call Transcript: Q4 2025


LifeStance Health Group Annual report: Q4 2025

Feb 25, 2026, 8:30 AM EST - 4 months ago

LifeStance Health Group Annual report: Q4 2025


LifeStance Health Group Earnings release: Q4 2025

Feb 25, 2026, 8:30 AM EST - 4 months ago

LifeStance Health Group Earnings release: Q4 2025


LifeStance Health Group Slides: Q4 2025

Feb 25, 2026, 8:30 AM EST - 4 months ago

LifeStance Health Group Slides: Q4 2025


LifeStance reports Q4 EPS 2c, consensus 5c

2026-02-25T11:17:25.000Z - 4 months ago

LifeStance reports Q4 EPS 2c, consensus 5c


LifeStance Reports Fourth Quarter and Full Year 2025 Results

Feb 25, 2026, 6:00 AM EST - 4 months ago

LifeStance Reports Fourth Quarter and Full Year 2025 Results


LifeStance Health Group Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

LifeStance Health Group Earnings Call Transcript: Q3 2025


LifeStance Health Group Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

LifeStance Health Group Quarterly report: Q3 2025


LifeStance Health Group Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

LifeStance Health Group Earnings release: Q3 2025


LifeStance Health Group Slides: Q3 2025

Nov 6, 2025, 8:30 AM EST - 8 months ago

LifeStance Health Group Slides: Q3 2025


LifeStance Reports Third Quarter 2025 Results

Nov 6, 2025, 6:00 AM EST - 8 months ago

LifeStance Reports Third Quarter 2025 Results


LifeStance to Present at the UBS Global Healthcare Conference

Oct 28, 2025, 4:10 PM EDT - 8 months ago

LifeStance to Present at the UBS Global Healthcare Conference


Sarah Personette Appointed to LifeStance Board of Directors

Aug 22, 2025, 9:00 AM EDT - 10 months ago

Sarah Personette Appointed to LifeStance Board of Directors


LifeStance Health Group Earnings Call Transcript: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

LifeStance Health Group Earnings Call Transcript: Q2 2025


LifeStance Health Group Quarterly report: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

LifeStance Health Group Quarterly report: Q2 2025


LifeStance Health Group Earnings release: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

LifeStance Health Group Earnings release: Q2 2025


LifeStance Health Group Slides: Q2 2025

Aug 7, 2025, 8:30 AM EDT - 11 months ago

LifeStance Health Group Slides: Q2 2025


LifeStance Reports Second Quarter 2025 Results

Aug 7, 2025, 6:00 AM EDT - 11 months ago

LifeStance Reports Second Quarter 2025 Results


LifeStance Names Vaughn Paunovich as Chief Technology Officer

May 14, 2025, 9:00 AM EDT - 1 year ago

LifeStance Names Vaughn Paunovich as Chief Technology Officer


LifeStance Health Group Earnings Call Transcript: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

LifeStance Health Group Earnings Call Transcript: Q1 2025


LifeStance Health Group Quarterly report: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

LifeStance Health Group Quarterly report: Q1 2025


LifeStance Health Group Earnings release: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

LifeStance Health Group Earnings release: Q1 2025


LifeStance Health Group Slides: Q1 2025

May 7, 2025, 8:30 AM EDT - 1 year ago

LifeStance Health Group Slides: Q1 2025


LifeStance Reports First Quarter 2025 Results

May 7, 2025, 6:00 AM EDT - 1 year ago

LifeStance Reports First Quarter 2025 Results


LifeStance Health Group Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

LifeStance Health Group Proxy statement: Proxy Filing


LifeStance Health Group Proxy statement: Proxy Filing

Apr 23, 2025, 8:00 AM EDT - 1 year ago

LifeStance Health Group Proxy statement: Proxy Filing


LifeStance Health Group Earnings Call Transcript: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

LifeStance Health Group Earnings Call Transcript: Q4 2024


LifeStance Health Group Annual report: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

LifeStance Health Group Annual report: Q4 2024


LifeStance Health Group Earnings release: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

LifeStance Health Group Earnings release: Q4 2024


LifeStance Health Group Slides: Q4 2024

Feb 27, 2025, 8:30 AM EST - 1 year ago

LifeStance Health Group Slides: Q4 2024


LifeStance Reports Fourth Quarter and Full Year 2024 Results

Feb 27, 2025, 6:00 AM EST - 1 year ago

LifeStance Reports Fourth Quarter and Full Year 2024 Results


LifeStance Health Group Earnings Call Transcript: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

LifeStance Health Group Earnings Call Transcript: Q3 2024


LifeStance Health Group Quarterly report: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

LifeStance Health Group Quarterly report: Q3 2024


LifeStance Health Group Earnings release: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

LifeStance Health Group Earnings release: Q3 2024


LifeStance Health Group Slides: Q3 2024

Nov 7, 2024, 8:30 AM EST - 1 year ago

LifeStance Health Group Slides: Q3 2024


LifeStance Reports Third Quarter 2024 Results

Nov 7, 2024, 6:00 AM EST - 1 year ago

LifeStance Reports Third Quarter 2024 Results


LifeStance Health Group Earnings Call Transcript: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

LifeStance Health Group Earnings Call Transcript: Q2 2024


LifeStance Health Group Quarterly report: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

LifeStance Health Group Quarterly report: Q2 2024


LifeStance Health Group Earnings release: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

LifeStance Health Group Earnings release: Q2 2024


LifeStance Health Group Slides: Q2 2024

Aug 8, 2024, 8:30 AM EDT - 2 years ago

LifeStance Health Group Slides: Q2 2024


LifeStance Reports Second Quarter 2024 Results

Aug 8, 2024, 6:00 AM EDT - 2 years ago

LifeStance Reports Second Quarter 2024 Results


KirkKerkorkian
KirkKerkorkian Jun. 16 at 8:58 PM
$LFST oh, if the liabilities on this balance sheet could speak… 😱
0 · Reply
Trader_Ty
Trader_Ty Jun. 12 at 11:48 AM
0 · Reply
MITCH1099
MITCH1099 May. 29 at 8:35 PM
$LFST LifeStance Health is delivering strong, profitable growth in outpatient mental health. Q1 2026 Highlights Revenue $403.5M (+21% YoY) Adj. EBITDA $51.1M (+48%) Net income turned positive at $14.2M 2026 Guidance (Raised) Revenue $1.64–1.68B (~17% growth) Adj. EBITDA $200–220M Outlook Analysts forecast 13–15% annual revenue growth and 50% EPS growth. Margin expansion continues toward mid-teens. Valuation $7.80/share. Consensus Buy with average target $9.86–10.72 (27–37%+ upside). Bottom Line Attractive growth story with accelerating profitability and meaningful analyst upside.
1 · Reply
Ld149
Ld149 May. 22 at 3:56 PM
$LFST This stock was supposed to go up after a great Q1 earnings report. But the 35 million sellout of stock pull this back a lot. ON top of that leaderhsip is selling stock like there is no tomorrow.... WTF are you thinking?
1 · Reply
NVDAMillionaire
NVDAMillionaire May. 20 at 7:37 PM
$LFST Outstanding article that hits the mark on LFST's current state. So if you want to refresh your LFST insights or learn about LFST from scratch, this is a must read. https://everyticker.com/quote/LFST/analysis/lifestance-health-from-cash-burn-to-capital-returns-as-ai-driven-productivity-fuels-margin-inflection-nasdaq-lfst
0 · Reply
KirkKerkorkian
KirkKerkorkian May. 20 at 11:13 AM
$LFST @TA_Kongen
0 · Reply
KirkKerkorkian
KirkKerkorkian May. 20 at 11:13 AM
$LFST how. did. this. grow. this. quickly? not. operationally. possible.
1 · Reply
RunnerSignals
RunnerSignals May. 12 at 8:40 PM
3 setups the crowd hasn't priced in yet $WFRD RSI jumped 10pts in one session. $LFST profits up 1900%, institutions buying not retail. $OUST 92% to target, quiet accumulation for 3 days
1 · Reply
OpenOutcrier
OpenOutcrier May. 8 at 11:52 AM
$LFST (-11.9% pre) LifeStance Health prices 35 million share secondary offering at $8.15 https://ooc.bz/l/101594
0 · Reply
KirkKerkorkian
KirkKerkorkian May. 8 at 10:09 AM
$LFST 20% + 6M share shelf - at earnings. really??? 🤔 🧐 🤨
1 · Reply
kshonstocks
kshonstocks May. 7 at 10:57 PM
$LFST LFST offering paniic shd be great opptnty their eps was v gd
0 · Reply
WeighProtein
WeighProtein May. 7 at 10:47 PM
$LFST Will short this
1 · Reply
Grouphome
Grouphome May. 7 at 7:27 PM
0 · Reply
StocktwitsEarnings
StocktwitsEarnings May. 7 at 10:21 AM
$LFST Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.04 • Reported revenue of $403.48M up 21.17% YoY • LifeStance Health Group Inc is raising full year 2026 revenue expectations to $1.64B to $1.68B, Center Margin to $547M to $571M, and Adjusted EBITDA to $200M to $220M.
0 · Reply
buyitall888
buyitall888 Apr. 28 at 9:47 PM
$LFST time to load up huge
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 28 at 12:13 PM
$LFST (+4.5% pre) LifeStance Health Group Set to Join S&P SmallCap 600 https://ooc.bz/l/100148
0 · Reply
SuperGreenToday
SuperGreenToday Apr. 22 at 8:37 PM
$LFST Share Price: $6.91 Contract Selected: Oct 16, 2026 $5 Calls Buy Zone: $2.07 – $2.55 Target Zone: $3.78 – $4.61 Potential Upside: 73% ROI Time to Expiration: 176 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Diddyparty
Diddyparty Feb. 26 at 2:44 PM
$LFST these losers glad I sold my April calls
0 · Reply
OpenOutcrier
OpenOutcrier Feb. 26 at 1:52 PM
$LFST (-7.7% pre) Form 424B7 LifeStance Health Group, https://ooc.bz/l/94835
0 · Reply